ANGIOTECH PHARMACEUTICALS INC Capital Expenditures
ANGIOTECH PHARMACEUTICALS INC reported Capital Expenditures of $2.12 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2013-03-28
- ANGIOTECH PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2012-12-31 was $819.00K.
- ANGIOTECH PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2012-09-30 was $447.00K, a 28.08% increase year-over-year.
- ANGIOTECH PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2012-06-30 was $436.00K.
- ANGIOTECH PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2012-03-31 was $413.00K.
- ANGIOTECH PHARMACEUTICALS INC payments to acquire property, plant, and equipment for fiscal 2012 was $2.12M.
| Period end | Payments to Acquire Property, Plant, and Equipment 2 month | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 5 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 8 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|---|---|
| 2012-12-31 | $819.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $1.27M derived: sum of 2 quarters · filed 2013-03-28 | $1.70M derived: sum of 3 quarters · filed 2013-03-28 | $2.12M 10-K · filed 2013-03-28 | |||
| 2012-09-30 | $447.00K 10-Q · filed 2012-11-14 | $883.00K derived: sum of 2 quarters · filed 2012-11-14 | $1.30M 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | $436.00K 10-Q/A · filed 2012-09-13 | $849.00K 10-Q/A · filed 2012-09-13 | |||||
| 2012-03-31 | $413.00K 10-Q · filed 2012-05-15 | ||||||
| 2011-12-31 | $1.00M 10-K · filed 2013-03-28 | ||||||
| 2011-09-30 | $349.00K 10-Q · filed 2012-11-14 | $734.00K 10-Q · filed 2012-11-14 | |||||
| 2011-06-30 | $385.00K 10-Q/A · filed 2012-09-13 |